Business news – Page 94
-
BusinessIndia pushes for emergency drug licences
Government looks set to force licensing of three patented cancer drugs
-
Business
UK companies struggling with Reach
Regulation is ‘elephant in the room’ as manufacturers fail to recognise implications
-
Business
Laropiprant recalled
Merck & Co says it is recalling Tredaptive tablets, approved in the EU for treating patients with high cholesterol
-
Business
Pharma industry 'strategic crisis'
The problem is shrinking margins, caused by price and cost pressure, regulatory change and expiring patents, report says
-
Business
Dow Corning to reduce roster by 500
Company says it must respond to oversupplied markets, high raw materials costs and poor growth in many regions
-
Business
EPA focuses on five chemicals
Risk assessments for five chemicals put out for public consultation
-
Business
Illumina investment push
$450 million deal for privately owned US firm Verinata Health, which makes chromosomal tests
-
Business
Wellcome Trust launches investment wing
Trust provides £200 million to create Syncona, which will support innovative healthcare businesses
-
-
Business
TB drug milestone for bedaquiline
First TB drug with a new mechanism of action for 40 years wins approval
-
Business
Clariant sells business bundle for CHF500m
Textile, paper and emulsion businesses to go to US investment firm
-
Business2012 pharma industry roundup
What were the bigger stories? And how did the industry fare overall?
-
OpinionFear of the unknown
How do you reconcile the need for personal safety with unfamiliar compounds, asks Derek Lowe
-
Business
Gilead buys YM for $510m
Deal gives Gilead access to Janus kinase inhibitor CYT387 for the treatment of myelofibrosis
-
Business
AkzoNobel sells $1bn chunk of paints business
North American decorative paints business was responsible for 7% of total AkzoNobel sales in 2011, amounting to $1.5 billion
-
Business
Single EU patent agreed for 2014
European commission says long awaited single patent will cut cost of filing by 87%
-
Business
BP shifting ethanol focus to Brazil
Company to invest $350 million to expand production from sugarcane in Brazil
-
Business
Pfizer's lost gold
A stash of gold dust bought for $700,000 last year has gone missing from a Pfizer lab in St Louis, Missouri, US
-
Business
EU companies increasing R&D
Difficult economic climate has not diminished EU enthusiasm for R&D